Lukasz Gondek, MD, PhD
Hematologic Malignancy
Highlights
Johns Hopkins Affiliations:
- Johns Hopkins School of Medicine Faculty
About Lukasz Gondek
Primary Academic Title
Associate Professor of Oncology
Background
Dr. Gondek is an Assistant Professor of Oncology at the Johns Hopkins University School of Medicine in the Division of Hematologic Malignancies. Dr. Gondek received his medical degree from the University of Silesia, Poland and his Ph.D. from the University of Warsaw, Poland. He completed his residency in internal medicine at the Cleveland Clinic and his fellowship training in hematology at the Johns Hopkins University. He joined the faculty in 2014.
Dr. Gondek’s primary research is to better understand the role of molecular events in initiation and progression of myelodysplastic syndromes and leukemia as well as develop novel targeted therapies to prevent disease progression and relapse.
Dr. Gondek has a clinical interest in hematologic malignancies and in particular myelodysplastic syndromes and acute myeloid leukemia. He is an attending on the inpatient adult leukemia service.
Centers and Institutes
Clinical Trial Keywords
Myelodysplastic Syndrome, Bone Marrow Failures, Leukemia
Contact for Research Inquiries
1650 Orleans Street
Room 290
Baltimore, MD 21287
Phone: (410) 955-0458
Research Interests
Bone Marrow Failures, Clonal Hematopoiesis, Myelodysplastic Syndrome, Stem Cells
Research Summary
Dr. Gondek’s primary research is to better understand the role of molecular events in initiation and progression of myelodysplastic syndromes and leukemia as well as develop novel targeted therapies to prevent disease progression and relapse.
Selected Publications
Gondek LP, Tiu R, Haddad AS, O'Keefe CL, Sekeres MA, Theil KS, Maciejewski JP. Single nucleotide polymorphism arrays complement metaphase cytogenetics in detection of new chromosomal lesions in MDS. Leukemia. 2007;21(9):2058- 2061
Gondek LP, Tiu R, O'Keefe CL, Sekeres MA, Theil KS, Maciejewski JP. Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML. Blood. 2008;111(3):1534-1542
Gondek LP, Zheng G, Ghiaur G, DeZern AE, Matsui W, Yegnasubramanian S, Lin MT, Levis M, Eshleman JR, Varadhan R, Tucker N, Jones R, Gocke CD. Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation. Leukemia. 2016 Sep;30(9):1916-20.
Jerez A, Gondek LP, Jankowska AM, Makishima H, Przychodzen B, Tiu RV, O'Keefe CL, Mohamedali AM, Batista D, Sekeres MA, McDevitt MA, Mufti GJ, Maciejewski JP. Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012;30(12):1343-1349
Lim Y, Gondek L, Li L, Wang Q, Ma H, Huso DL, Foerster S, Marchionni L, McGovern K, Watkins DN, Peacock CP, Levis M, Smith BD, Merchant AA, Small D, Matsui W. The Hedgehog pathway enhances aberrant FLT3 signaling in myeloid leukemia. Science Translational Medicine. 2015 Jun 10;7(291):291-296
Honors
- Clinician Scientist Career Development Award, Johns Hopkins School of Medicine, 1/1/17
- Edward P. Evans Fellowship, AA & MDS International Foundation, 7/1/14
Memberships
- American Society of Hematology
- American Society of Oncology
Locations
- Sidney Kimmel Comprehensive Cancer Center
- 401 North Broadway Street, Weinberg BLDG, Baltimore, MD 21287
- phone: 410-955-8964
- fax: 410-367-2194
Expertise
Education
Johns Hopkins University School of Medicine
Fellowship, Hematology, 2014The Medical University of Warsaw
Graduate School, PhD, 2013Cleveland Clinic
Residency, Internal Medicine, 2011University of Silesia School of Medicine
Medical Education, MD, 2003Board Certifications
Hematology
American Board of Internal Medicine, 2013Insurance
- Aetna
- CareFirst
- Cigna
- First Health
- Geisinger Health Plan
- HealthSmart/Accel
- Humana
- Johns Hopkins Health Plans
- MultiPlan
- Pennsylvania's Preferred Health Networks (PPHN)
- Point Comfort Underwriters
- Private Healthcare Systems (PHCS)
- UnitedHealthcare
- Veteran Affairs Community Care Network (Optum-VACCN)